A
Abbott India Ltd
NSE:ABBOTINDIA
Abbott India Ltd
NSE:ABBOTINDIA
Price:
26 192.05 INR
0.32%
Market Closed
Updated:
May 27, 2024
P/OCF
Price to OCF
Price to OCF
45.9
Current
45.8
Median
17
Industry
Higher
than median
Higher
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=45.9
Market Cap
/
556.6B
Operating Cash Flow
12.1B
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| IN |
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
556.6B INR | 45.9 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | -19 905 436.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
767.4B USD | 208.8 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4.1T DKK | 44.3 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 6 923.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
353.7B USD | 15.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
328B USD | 22.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
190.6B GBP | 25 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
183.7B CHF | 11.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
179.5B CHF | 14.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
163.7B USD | 19.1 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
